Axonal excitability is an important determinant for the accuracy, direction, and velocity of neuronal signaling. The mechanisms underlying spike generation in the axonal initial segment and transmitter release from presynaptic terminals have been intensely studied and revealed a role for several specific ionic conductances, including the persistent sodium current (I NaP ). Recent evidence indicates that action potentials can also be generated at remote locations along the axonal fiber, giving rise to ectopic action potentials during physiological states (e.g., fast network oscillations) or in pathological situations (e.g., following demyelination). Here, we investigated how ectopic axonal excitability of mouse hippocampal CA1 pyramidal neurons is regulated by I NaP . Recordings of field potentials and intracellular voltage in brain slices revealed that electrically evoked antidromic spikes were readily suppressed by two different blockers of I NaP , riluzole and phenytoin. The effect was mediated by a reduction of the probability of ectopic spike generation while latency was unaffected. Interestingly, the contribution of I NaP to excitability was much more pronounced in axonal branches heading toward the entorhinal cortex compared with the opposite fiber direction toward fimbria. Thus, excitability of distal CA1 pyramidal cell axons is affected by persistent sodium currents in a direction-selective manner. This mechanism may be of importance for ectopic spike generation in oscillating network states as well as in pathological situations.
Fast and reliable spike propagation along axons depends on the expression and localization of various voltage-dependent ion channels. Accordingly, voltage-sensitive sodium channels are densely clustered at the axon initial segment (AIS) and at nodes of Ranvier of myelinated axons (Dodge and Cooley 1973; Fleidervish et al. 2010; Kole and Stuart 2012) . Mammalian sodium channels are constituted from a diverse family of alpha and auxiliary subunits, giving rise to a variety of sodium currents with different voltage dependences and kinetics (Bezanilla 2008; Ahern et al. 2016) .
One component of voltage-gated sodium currents is characterized by the lack of inactivation (Dubois and Bergman 1975; Kiss 2008) . The resulting persistent sodium current (I NaP ) supports input integration by amplifying dendritic excitatory postsynaptic potentials (EPSPs) (Stuart and Sakmann 1995; Fricker and Miles 2000; Vervaeke et al. 2006) , regulates neuronal excitability (Wu et al. 2005; Bean 2007; Kole 2011) , and mediates depolarizing afterpotentials of somatically recorded action potentials (Yue et al. 2005; Ceballos et al. 2017) , which may contribute to bursting behavior of cortical pyramidal cells (Su et al. 2001; Fekete et al. 2009; Sheroziya et al. 2009) . Less is known, however, about the role of I NaP in distal axons. Non-inactivating current components have been found in axon terminals, but their functional significance remains unclear (Huang and Trussell 2008; Kim et al. 2010) . Following demyelination, I NaP is increased along the axon, contributing to sustained depolarizations and, possibly, ectopic action potential generation (Hamada and Kole 2015) . Together, it seems likely that I NaP regulates the propagation of action potentials in distal axonal compartments.
Expression of I NaP in remote parts of the axon may also facilitate the generation of spikes distal from the AIS (Lachance et al. 2014) . Such ectopically generated action potentials (eAP) have been observed in several preparations in vitro (B€ ahner et al. 2011) and in vivo (Epsztein et al. 2010) . They may provide an important signaling mechanism in cortical neurons, allowing spike generation independent from the generation of supra-threshold synaptic potentials at the AIS. At the same time, antidromic invasion of somato-dendritic compartments by eAP may support dendritic synaptic plasticity (Bukalo et al. 2013) . In pathological conditions, increased eAP frequency may promote dysfunctional information processing. I NaP contributes to such increased ectopic firing following demyelination (Rasminsky 1984; Hamada and Kole 2015) , in neuropathic pain (Costigan et al. 2009 ) and in chronically epileptic tissue (Stafstrom 2007) . In addition, sodium influx via I NaP may also de-regulate ion homeostasis in damaged axons, contributing to axonal pathology (Stys et al. 1993; Trapp and Stys 2009 ).
Thus, I NaP is an important regulator of axonal excitability. Here, we analyzed the role of I NaP for ectopic spike generation in CA1 pyramidal cells. It is well established that these neurons express I NaP in proximal compartments (Yue et al. 2005; Royeck et al. 2008) where it contributes to depolarizing afterpotentials and regulation of spike patterns (French and Gage 1985; Azouz et al. 1996; Metz et al. 2005; Golomb et al. 2006) . Since CA1 pyramidal cells regularly generate eAP during fast network oscillations in vitro (B€ ahner et al. 2011) , we asked whether I NaP affects excitability of distal axonal compartments in these neurons. Because I NaP channels are constituted by the same alpha subunits which mediate fast inactivating, transient sodium current, we made use of pharmacological tools to block I NaP and tested whether this affected the ability of extracellular stimulation in the alveus to trigger spikes by exciting distal axons. Persistent sodium currents were blocked by riluzole, a benazol used in the therapy of amyotrophic lateral sclerosis (Urbani and Belluzzi 2000; Bellingham 2011) or by phenytoin, a first-line anticonvulsant drug (Chao and Alzheimer 1995; Yue et al. 2005; Colombo et al. 2013) .
We report a significant contribution of I NaP to distal axonal excitability and eAP generation in CA1 pyramidal neurons. Block of I NaP decreased the probability of ectopic action potential generation following stimulation of the axon. Surprisingly, the effects were stronger in the axonal branch projecting to subiculum/entorhinal cortex as compared with fimbria/fornix, pointing toward a functional asymmetry in the regulation of axonal excitability.
Material and methods
Preparation of mouse brain slices Horizontal brain slices (450 lm thick) containing the hippocampus and entorhinal cortex were obtained from male C57BL/6N mice, 4-8 weeks old, 20-25 g) using standard proceedings (Fischer et al. 2014) . Mice were purchased from Charles River Laboratories (Sulzfeld, Germany, Strain Code: 027) and were taken care of in the Interfaculty Biomedical Research Facility in Heidelberg. Housing was provided in Makrolon II cages with a maximum of three animals and tissue nesting material made of cellulose. Animals had ad libitum access to food and water. All experimental protocols were conducted in compliance with German law and with the approval of the state government of Baden-W€ urttemberg (Project T100/15). In order to minimize animal suffering we decapitated mice under deep CO 2 -induced anesthesia and used up to 6 slices per animal for experiments. Afterward, brains were rapidly removed and placed in cold (3 AE 1°C) oxygenated (95% 0 2 and 5% CO 2 ) artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 3 KCl, 1.6 CaCl 2 , 1.8 MgSO 4 , 26 NaHCO 3 , 1.25 NaH 2 PO 4 , and 10 glucose. In order to preserve maximal axonal length, slices were cut with an angle of 10°toward the ventral side using a vibratome (Leica VT1200S, Nussloch, Germany). Then, they were transferred to a Haas-type interface chamber, which was perfused with ACSF at a rate of 1.2-1.4 mL/min at 34°C (Haas et al. 1979) . Slices rested for at least 2 h before electrophysiological recordings. Since this was a hypothesis generating study, no sample size calculation was performed. We chose the minimal necessary sample size to determine p values ≥ 0.01 with the Wilcoxon matched-pairs signed-ranks test, i.e. n = 7. No randomization or blinding methods were used in this study. The study was not pre-registered.
Electrophysiological recordings
Local field potentials were recorded using ACSF filled glass electrodes (Science Products, Hofheim, Germany, Cat. No. GB200F-10) with a tip diameter of 2-3 lm. All electrodes were pulled with a DMZ-Universal-Electrodes-Puller (Zeitz, Martinsried, Germany). Signals were amplified x100, high-pass filtered at 0.3 Hz and low-pass filtered at 2 kHz using an EXT 10-2F amplifier (npi electronics, Tamm, Germany). Afterward, signals were digitized at 20 kHz with an analog-to-digital converter (Cambridge Electronic Design (CED) MICRO 1401 mkII, Cambridge, UK) and saved using Spike2 software (CED, Cambridge, UK).
For intracellular recordings, sharp microelectrodes (tip resistance 90-180 MO) were pulled using 1.0-mm borosilicate capillaries (Harvard Apparatus, Cambridge, UK, . Electrodes were filled with 2 mM K-acetate containing 1% biocytin (SigmaAldrich, Taufkirchen, Germany, Cat. No. B4261). We used biocytin staining to confirm typical pyramidal cell morphology and location after the experiment. Signals were recorded with a HS-9A x0.1 headstage and an Axoclamp-900A amplifier (Molecular Devices, San Jose, CA, USA). Raw data were low-pass filtered (10 kHz), amplified x10, and sampled at 20 kHz (CED MICRO 1401mkII, Spike2). Intracellular potentials were recorded in bridge mode, with repeated bridge balance controls during the experiments (À0.3 nA current pulses). Cells were accepted when they fulfilled the following criteria: Input resistance > 20 MO, action potential amplitude > 80 mV, stable resting membrane potential for at least 35 min without negative current injection and typical firing pattern of pyramidal cells. In addition, we required that ectopic action potentials could be evoked by distal axonal stimulation (see below) with somatic onset latency > 1.5 ms.
Electrical stimulation
Electrical stimuli were generated with an extracellular bipolar platinum/iridium electrode (75 lm tip separation, impedance 0.1 MO; MicroProbes, Gaithersburg, MD, USA, Cat. No. PI2ST30.1A3). Pulses of 0.1 ms were delivered with an Iso-Flex stimulus isolator (AMPI, Jerusalem, Israel) at intervals of 30 s. For each slice, stimulation intensity was adjusted to 60% of the maximal antidromic population spike (aPS) estimated by an input-output curve. For experiments with local drug application, stimulation intensity was adjusted to 30% of maximum. For intracellular experiments, the stimulation intensity was determined as the minimal intensity to reliably evoke ectopic action potentials (eAP). Electrodes were placed in the alveus, either close to subiculum or close to the CA3 region. To prevent recurrent excitation and inhibition following ectopic spike generation, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), N-methyl-D-aspartate (NMDA) and c-Aminobutyric acid (GABA) A receptors were blocked with 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), (D, L)-2-amino-5-phosphonovaleric acid (APV) and picrotoxin, respectively. Block of synaptic transmission was verified by monitoring the elimination of spontaneous sharp wave-ripple activity and by the disappearance of the synaptic field potential component after stimulation (Fig. 1b) . Stimulation artifacts were trimmed in the represented traces.
Drugs
Riluzole (10 lM, Cat. No. 0768), CNQX (30 lM, Cat. No. 1045). and APV (10 lM, Cat. No. 0105) were obtained from Tocris (Bristol, UK). Phenytoin (100 lM, Cat. No. PHR1139) and picrotoxin (100 lM, Cat. No. P1675) were obtained from Sigma-Aldrich (Taufkirchen, Germany). All drugs were bath applied by continuous perfusion. Picrotoxin was freshly dissolved in ACSF for each experiment. Phenytoin was applied from a stock solution in dimethylsulfoxide. The final dimethylsulfoxide concentration was 0.001%. Other drugs were applied from concentrated stock solutions in distilled water. Control experiments without riluzole or phenytoin saw no effects on aPS amplitude during 90 min of recording (n = 3). Riluzole and phenytoin were perfused for at least 30 min. Washout of riluzole and phenytoin effects on aPS amplitude was tested in an initial series of experiments, but was not successful after 30 min of perfusion with drug-free ACSF (riluzole: n = 8 for extra and n = 10 for intracellular recordings; see Tazerart et al. (2007) ; phenytoin: n = 3).
Local application Local applications of riluzole (100 lM) or ACSF (as a control) were performed using glass electrodes (tip diameter of~10 lm, Science Products, Hofheim, Germany, Cat. No. GB200F-10). The concentration of riluzole was higher than in bath applications to compensate for dilution effects due to diffusion within the slice and mixture with drug-free bath perfusion. Pipettes with long endings (~2 cm) were pulled on a Flaming/Brown P-97 Puller (Sutter Instruments, Novato, CA, USA) from 2.0 mm glass capillaries. Tips of pipettes were then broken under microscopic control. Application electrodes were gently placed in the alveus between stimulation and recording electrodes (Fig. 2a) . In order to prevent diffusion of drug toward the recording electrode, the flow of perfusion was always heading toward the stimulation electrode. The glass pipette was removed from the slice immediately after application of ACSF or riluzole by light air pressure from a connected syringe. Control experiments with cresyl violet confirmed that substances were delivered in a restricted area of~200 lm diameter.
Data analysis
Data analysis was performed off-line with custom-made routines in MATLAB (The Mathworks, Natick, MA, USA). Field potential values for each experiment were calculated as the mean of 15 stimulations under control conditions and at the end of drug application (Fig. 1c) . Amplitude of aPS was measured as the difference between an extrapolated baseline and the voltage minimum following stimulation as shown in Fig. 1d (top). Amplitudes < 100 lV were not considered, as baseline noise was AE 25 lV. Onset latency of aPS was estimated as the time difference between the start of the stimulation artifact and response onset ( Fig. 1d , middle). Peak latency was measured from the stimulation artifact to the negative voltage peak (Fig. 1d , bottom). For local application, each aPS amplitude after application was normalized to the mean amplitude of the last 10 aPS before application. Inputoutput curves were obtained by normalizing each individual curve to its respective maximum. For the analysis of drug-induced changes in excitability for stimulation trains (average of three repetitions), the responses under the drug conditions were normalized to the control responses. In all experiments we confirmed that the train stimulations per se did not induce changes of aPS amplitude. For intracellular experiments, negative and positive current pulses of 200 ms duration were injected to measure intrinsic properties of cells (Fig. 4b ). Resting membrane potential was corrected using the tip potential after withdrawal from the cell and for recordings > 2 h combined with measurements for firing threshold. Antidromic spikes were identified by their short latency and lack of a preceding depolarization. Afterdepolarization of action potentials was determined as the difference between the average resting membrane potential during 40 ms before the action potential and the average membrane potential during 10 ms after the fast repolarization (Metz et al. 2005) .
Statistical analysis
Statistical analysis was performed with GraphPad Prism version 6.05 (InStat, San Diego, USA) and R version 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria). Data are presented as mean AE SEM. Values were compared by paired two-tailed Student t-test for normally distributed data, Wilcoxon matched-pairs signedranks test for non-normally distributed data. Linear regressions and ANOVA were tested with the appropriate post hoc test. Correlations of parameters were confirmed when the slope of standard linear regression was significantly different from zero. A p value < 0.05 was regarded significant. For all presented data: *p < 0.05, **p < 0.01, ***p < 0.001.
Results
I NaP blockers decrease antidromic population spikes Excitability of distal axons was measured by generating ectopic action potentials (eAP). Stimulation electrodes were placed in the axonal layer (alveus) at a minimum distance of 200 lm from the recording electrode lateral to the cell axis (Fig. 1a) . The location of the recording electrode in the pyramidal layer of CA1 (Fig. 1a) lowered the probability of recording from long-range-projecting interneurons, which are preferentially located in stratum radiatum or stratum oriens (Melzer et al. 2012) .
Stimulating axons in the alveus regularly elicited a field response in the pyramidal layer of CA1. This field response had a characteristic negative component (Fig. 1b) , representing multiple synchronous antidromic action potentials (Franco et al. 2015) . The following positive component (Fig. 1b, left) arises due to recurrent synaptic excitation within CA1. Because we were only interested in the excitability of axons, fast synaptic excitation was blocked with CNQX, APV, and picrotoxin (Fig. 1b right) . This field response was then considered as an antidromic population spike (aPS).
To assess the influence of persistent sodium current (I NaP ) blockers on aPS, we applied riluzole (10 lM) (Urbani and Belluzzi 2000) and phenytoin (100 lM) (Yue et al. 2005) through the bath solution for 30 min (Fig. 1c) . Riluzole reduced aPS amplitude to 70.1 AE 6.9% of control (n = 8 slices from six animals, paired t-test, p = 0.005; Fig. 1e) . Similarly, phenytoin reduced aPS amplitude to 85.9 AE 6.1% of control (Wilcoxon test, n = 7 slices from six animals, p = 0.031; Fig. 1e ). This reduction in aPS amplitude is most easily explained by a reduction in axonal excitability, resulting in fewer cells firing ectopic action potentials (eAP) after stimulation.
Riluzole did not dramatically alter onset latency (control vs. riluzole, 1.67 AE 0.45 ms vs. 1.73 AE 0.51 ms, n = 8, paired t-test, p = 0.36; Fig. 1e ) or peak latency (2.11 AE 0.43 ms vs. 2.12 AE 0.46 ms, n = 8, paired t-test, p = 0.48; Fig. 1e ). Likewise, phenytoin did not significantly change onset latency (control vs. phenytoin, 1.77 AE 0.42 ms vs. 1.84 AE 0.46 ms, n = 7, paired t-test, p = 0.17; Fig. 1e ) or peak latency (2.84 AE 0.57 ms vs. 2.86 AE 0.55 ms, n = 7, paired t-test, p = 0.61; Fig. 1e ). Thus, axonal conduction velocity is not altered by both substances.
Together, our results suggest that the observed reduction in aPS amplitude is caused by suppression of I NaP in distal pyramidal cell axons. As a direct test of this hypothesis, we locally applied riluzole directly to the axonal bundle in the alveus in close proximity to the stimulation electrode (Fig. 2a) . In these experiments, riluzole was applied at 100 lM to compensate for the expected dilution within the ACSF-perfused slice (see Methods). To exclude potential mechanical artifacts, ACSF was applied as a control prior to riluzole in all slices tested (Fig. 2b) . In all nine slices, local application of ACSF induced no or minimal effects. In contrast, local application of riluzole significantly decreased aPS amplitude (n = 9 slices from five animals, one-way ANOVA, Barlett post hoc test, riluzole vs. ACSF; p < 0.001, Fig 2c) . Thus, after 1.5-min riluzole reduced aPS amplitude to 88.0 AE 2.2% of control values in ACSF (n = 9, paired t-test, p < 0.001). Similar to experiments with bath application, local application of riluzole to distal axons of CA1 pyramidal neurons did not greatly alter aPS onset latency (ACSF vs. riluzole, 1.48 AE 0.13 ms vs. 1.46 AE 0.15 ms, n = 9, paired t-test, p = 0.71) or aPS peak latency (3.19 AE 0.12 ms vs. 3.17 AE 0.11 ms, n = 9, paired t-test, p = 0.63).
Thus, suppression of excitability by riluzole is indeed mediated by block of I NaP in peripheral axons.
Riluzole decreases axonal excitability
To further investigate the mechanism behind the modulation of population spikes by I NaP blockers, we performed intracellular recordings from CA1 pyramidal neurons (Fig. 3a) . Simultaneous recordings of field potentials were used to confirm the antidromic nature of the simulated action potentials. Intracellular recordings of ectopically generated action potentials in putative CA1 pyramidal neurons were performed before and after application of 10 lM riluzole (Fig. 3b) . The drug induced two prominent effects: First, riluzole significantly diminished eAP firing probability (0.94 AE 0.02 vs. 0.31 AE 0.12, n = 12 cells from 12 animals, Wilcoxon test, p = 0.002; Fig. 3c ). Second, riluzole also significantly hyperpolarized the cells by 4.9 AE 1.0 mV (n = 12, paired t-test, p = 0.0009; Fig. 3c ). To test whether the somatic hyperpolarization caused the loss of eAP, neurons were depolarized to baseline potential. However, even under these conditions, eAP probability did not recover (0.31 AE 0.12 vs. 0.24 AE 0.03, n = 6; Fig. 3b and c) . In contrast, increasing stimulation intensity restored eAP (0.31 AE 0.12 vs. 0.95 AE 0.03, n = 4, Fig. 3b and c) , n = 11 cells from 11 animals, paired t-test, p = 0.568; Fig. 4c ). This result is consistent with previous findings by Urbani and Belluzzi (2000) . Taken together these results suggest that riluzole reduces the probability of ectopic spike generation by changing excitability of the distal axon.
Intracellular recordings of eAP revealed a further typical effect of the reduction of I NaP : The characteristic afterdepolarization (ADP) following action potentials in CA1 pyramidal cells (Storm 1987; Azouz et al. 1996; Bean 2007 ) was reduced by À2.9 mV (paired t-test, n = 11, p = 0.01, Fig. 4c ), in line with a previous report (Yue et al. 2005) .
The reduction of the ADP was linearly correlated with the negative shift of somatic resting membrane potential (Linear Regression, adjusted r 2 = 0.55, Dunnett post hoc test, n = 11; p < 0.001, Fig. 4c ), indicating that the effect was not a result of hyperpolarization (for comparison, see the gray trace 'riluzole + curr' in Fig. 4c ). Of 12 tested neurons, five showed bursts of action potentials in response to a depolarizing current injection in drug-free ACSF. Under riluzole, this intrinsic bursting response was reduced in 4/5 neurons and converted to regular firing behavior in 1/5 (Fig. 4b) , similar to Yue et al. (2005) .
Asymmetric effect of riluzole on aPS for different axonal projections
The axon of CA1 pyramidal neurons branches into two major fibers projecting to the entorhinal cortex (EC) and the fimbria (Fimb). While the projection to EC stays local (Naber et al. 2001) , the branch heading toward fimbria projects to ipsilateral anterior brain regions (Arszovszki et al. 2014) . Hence, the two main branches support a local and a global projection, respectively. We checked whether this difference corresponds to a functional distinction of both axon branches. When we stimulated axons heading toward the *** entorhinal cortex (Alv?EC), riluzole reduced aPS amplitude to 72.6 AE 9.5% of control (n = 7 slices from seven animals, Wilcoxon test, p = 0.016; Fig. 5c ). However, when we stimulated the projection toward fimbria (Alv?Fimb), riluzole did cause a slight amplitude reduction which did not reach levels of significance (92.4 AE 3.7% of control, n = 7, Wilcoxon test, p = 0.11; Fig. 5c ). This discrepancy suggests that I NaP is less prevalent or functionally less important in the axon branch projecting toward fimbria. Onset latencies were not dramatically changed by riluzole. This applied to both stimulation sites (Stim Alv?Fimb: 0.88 AE 0.03 ms vs. 0.92 AE 0.03 ms, n = 7, paired t-test, p = 0.14; Stim Alv?EC: 1.35 AE 0.15 vs. 1.39 AE 0.17 ms, n = 7, paired t-test, p = 0.18; Fig. 5c ). Likewise, peak latencies did not greatly differ between control and riluzole conditions (Stim Alv?Fimb: 1.56 AE 0.05 ms vs. 1.58 AE 0.05 ms, n = 7; paired t-test, p = 0.20; Stim Alv?EC: 2.31 AE 0.20 ms vs. 2.51 AE 0.22 ms, n = 7; paired t-test, p = 0.09; Fig. 5c ).
Finally, we compared input-output curves for aPS before and after perfusion of riluzole between both axonal branches. In line with the asymmetric effects of I NaP block reported above, riluzole exclusively affected the input-output curve following stimulation of Alv?EC. At this stimulus location, the curves differed significantly (two-way ANOVA with Dunnett post hoc test, n = 7, p = 0.0004; Fig. 5d ). In contrast, when stimulating Alv?Fimb input-output curves were not significantly altered by riluzole (two-way ANOVA with Dunnett post hoc test, n = 7, p = 0.31; Fig. 5d ). Together, these findings point toward an unexpected asymmetry in the functional role of I NaP for axonal excitability in CA1 pyramidal cells.
Axonal excitability and slowly inactivating sodium current
Since stimulations were applied every 30 s, the observed effects of I NaP blockers were likely restricted to a permanent conductance. To determine the influence of I NaP blockers on the slowly inactivating component of the persistent sodium current (Zeng et al. 2016 ), we applied stimulation trains at frequencies of 10, 20, 40, and 100 Hz for 1 s.
Riluzole did affect mean aPS amplitudes at all frequencies ( Fig. 6 ; Alv?Fimb: n = 9 slices from seven animals, paired t-test, p 10 Hz = 0.008, p 20 Hz = 0.009, p 40 Hz = 0.040, p 100 Hz = 0.022; Alv?EC: n = 8 slices from six animals, Control Riluzole Riluzole + curr ANOVA, paired t-test or Wilcoxon test, *p < 0.05, ***p < 0.001.
Interestingly, at 100-Hz stimulation in the Alv?EC direction, riluzole changed the time course of aPS trains with a particularly strong reduction of aPS amplitudes within the first 400 ms (two-way ANOVA, Dunnett post hoc test for riluzole*time, n = 8, p < 0.001, Fig. 6c and d) . This finding suggests suppression of a slowly inactivating I NaP component during the train. Lower frequencies did not show this time course interaction (two-way ANOVA, Dunnett post hoc test for riluzole*time, for 10, 20, and 40 Hz, p > 0.46). We did not see a similar interaction effect stimulating Alv?Fimb at 100 Hz (two-way ANOVA, Dunnett post hoc test for riluzole*time, n = 9, p = 0.15, Fig. 6d ), in accordance with the functional asymmetry described above.
Discussion
We report a reduction of axonal excitability of CA1 pyramidal neurons by two different blockers of the persistent sodium current (riluzole and phenytoin). Upon electrical stimulation of the axon bundle in the alveus, antidromic population spikes were reduced by the drugs in extracellular recordings. Intracellular recordings revealed a decrease in probability of ectopic spike generation which could be reversed by increasing stimulation strength. Our results show a regulation of distal axonal excitability by I NaP . Interestingly, this effect is stronger in the axonal branch heading toward the entorhinal cortex, whereas I NaP does not play an overt role in the opposite branch, heading toward the fimbria.
A persistent (non-inactivating) sodium current component has first been described by (Dubois and Bergman 1975) . Subsequent work revealed that this current is present in multiple different neurons (Llinas 1988; Kiss 2008) , including CA1 pyramidal neurons (French et al. 1990; Azouz et al. 1996; Niespodziany et al. 2004; Vervaeke et al. 2006) . However, the observed effects of I NaP in these neurons are largely caused by channels located close to the soma, including the axon initial segment (French et al. 1990; Yue et al. 2005) . At these proximal locations, I NaP contributes to the integration of afferent synaptic potentials (Stuart and Sakmann 1995; Fricker and Miles 2000; Vervaeke et al. 2006) , spike afterdepolarization (Azouz et al. 1996; Metz et al. 2005) , and burst generation (Azouz et al. 1996; Su et al. 2001) . Much less is known about I NaP in peripheral axons. The current is present at axon terminals of the Calyx of Held (Huang and Trussell 2008; Kim et al. 2010) , where it could potentiate the influence of GABA, glycine, and acetylcholine (Huang and Trussell 2008) . In our study, however, we focused on a distal portion of the axonal shaft, asking whether I NaP also modulates excitability along the extension of the fiber. At this location, the presence and role of I NaP is much less clear. Recent data from demyelinated neocortical pyramidal cells show an increased expression of I NaP along their axons, supporting the generation of ectopic spikelets and spikes (Hamada and Kole 2015) . Our present data from CA1 pyramidal cells point toward a similar role of I NaP in the regulation of their axonal excitability. The effect was present under physiological conditions, indicating that I NaP does not only appear after demyelination.
Persistent sodium currents are mediated by the same alpha subunits of voltage-sensitive sodium channels which also mediate transient, rapidly inactivating inward currents. Interestingly, Na V 1.6 channels contribute strongly to I NaP (Rush et al. 2005) . Currently, the expression of these channels was confirmed at the distal AIS and the region distal to AIS (Hu et al. 2009 ). However, the peculiar kinetics of slowly or non-inactivating sodium currents results from interactions between 'normal' alpha-and auxiliary betasubunits, making it difficult to target them with high specificity. We, therefore, used two different established blockers of I NaP , riluzole and phenytoin, which showed convergent effects. Phenytoin efficiently inhibits the persistent current component in CA1 pyramidal cells (Niespodziany et al. 2004; Yue et al. 2005) ; but see (Zeng et al. 2016) , as well as in neocortical neurons (Chao and Alzheimer 1995; Colombo et al. 2013 ). Similar effects have been shown for riluzole on CA1 (Niespodziany et al. 2004) , respectively (Yue et al. 2005; Park et al. 2013) , and in neocortical neurons (Urbani and Belluzzi 2000; Spadoni et al. 2002) . It is, thus, likely that the observed reduction in axonal excitability results from block of axonal I NaP . A major contribution of somatically expressed persistent sodium currents is unlikely as the effects could not be reversed by somatic depolarization. Indeed, the stimulation site-dependent asymmetry and the effects of local drug application strongly suggest a local axonal effect.
Our experiments with prolonged train stimulation suggest that riluzole primarily affects the non-inactivating component of the persistent sodium current. However, following stimulation at a high-frequency (100 Hz) riluzole showed an additional transient effect, probably by reducing a slowly inactivating component of I NaP . In somatic patch clamp recordings from CA1 pyramidal cells, Zeng et al. (2016) found a major effect of phenytoin on the late phase of spike trains, in contrast to our early-phase effects. This apparent discrepancy may be due to different mechanisms of action between phenytoin and riluzole or to differences in somatic versus axonal ion channel composition. In any case, Zeng et al. (2016) , Colombo et al. (2013) , and our present work converge on the conclusion that I NaP blockers suppress the slowly inactivating component of I NaP .
What could be the functional significance of a persistent sodium current along the axon? Previous work has shown that CA1 pyramidal cells do indeed generate ectopic action potentials which are generated in axonal compartments far distal from the axon initial segment (B€ ahner et al. 2011; Traub et al. 2012) . Similar full or truncated spikes (spikelets) have been reported from neocortical layer 5 pyramidal cells (Epsztein et al. 2010) . It is very possible that ectopic axonal spike generation is a physiological signaling mechanism of axons, thereby generating action potentials largely independent from synaptic input. Indeed, this mechanism has been shown to underlie spiking of axons (Dugladze et al. 2012 ) and somata (B€ ahner et al. 2011 ) during high-frequency oscillations in vitro. This may be particularly relevant during propagation of sharp waveripple complexes from CA1 to deep layers of the EC (Roth et al. 2016) . Regulation of axonal excitability by I NaP may be an important determinant of information flow in such network processes.
Large parts of the membrane of central axons are shielded by myelin. It can be assumed that efficient inward sodium currents (both persistent and fast inactivating) are restricted to unmyelinated areas (Lachance et al. 2014) , that is, nodes of Ranvier, initial portions of the axon and small, unmyelinated axonal branches. Indeed, the lateral diffusion or enhanced efficacy of I NaP in demyelinated axons causes hyperexcitability and increased propensity for eAP (Hamada and Kole 2015) . This mechanism may underlie several pathophysiological phenomena, including dysfunctional information processing in demyelinated fiber tracts (Hamada and Kole 2015) , neuropathic pain (Lachance et al. 2014; Nicholson et al. 2014) , axonal hyperexcitability in motor neuron disease (Iwai et al. 2016; Shibuya et al. 2016) , neurodegeneration in multiple sclerosis (Trapp and Stys 2009) , and spasticity following spinal cord injury (Brocard et al. 2016) . Axonal hyperexcitation by increased I NaP might even play a causal role for neuronal damage and, hence, for the progression of some of these diseases (Waxman 2008; Iwai et al. 2016) . Indeed, riluzole appears to be efficient in clinical studies on spinal cord injury (Grossman et al. 2014; Fehlings et al. 2016) and has been used for many years to treat amyotrophic lateral sclerosis (Bellingham 2011) . It is presently unclear whether the anticonvulsant effect of phenytoin is related to effects on axonal hyperexcitability or exclusively to suppression of the well-established increase in perisomatic Na + influx (Chen et al. 2011; Royeck et al. 2015; Lopez-Santiago et al. 2017; Ottolini et al. 2017) .
In summary, our data reveal that I NaP regulates excitability of distal axons in CA1 pyramidal cells. The expression, localization, and modulation of persistent sodium currents are likely to affect ectopic action potential generation and, possibly, AP propagation in these cells. Axonal I NaP may play an important role for normal and pathological hippocampal network behavior.
